Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:149709-62-6
Molecular Formula:C24H29NO5
Alias
More Information
Entresto (Trade Name, With Valsartan Sodium); 4-[[(2S,4R)-5-Ethoxy-4-Methyl-5-Oxo-1-(4-Phenylphenyl)Pentan-2-Yl]Amino]-4-Oxobutanoic Acid; Ahu-377; 4-(((2S,4R)-1-([1,1'-Biphenyl]-4-Yl)-5-Ethoxy-4-Methyl-5-Oxopentan-2-Yl)Amino)-4-Oxobutanoic Acid; 4-(((2R,4R)-1-([1,1'-Biphenyl]-4-Yl)-5-Ethoxy-4-Methyl-5-Oxopentan-2-Yl)Amino)-4-Oxobutanoic Acid; (2R,4S)-5-(Biphenyl-4-Yl)-4-[(3-Carboxypropionyl)Amino]-2-Methylpentanoic Acid Ethyl Ester; (2R,4S)-5-([1,1'-Biphenyl]-4-Yl)-4-(3-Carboxypropanamido)-2-Methylpentanoic Acid; Ahu-377,149709-62-6; Ahu-37; Ahu377; Ahu 377
Brief Introduction
Sacubitril (INN developmental code name AHU-377) is an antihypertensive drug used in combination with valsartan. The combination drug valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name Entresto, is a treatment for heart failure. It was approved under the FDA's priority review process for use in heart failure on July 7, 2015.
CNY 22 Million
49950m²
100-500 People
CRO
CRO
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Sacubitril
/Sodium 4-Aminosalicylate Dihydrate
/Metoclopramide Hydrochloride
/Ambroxol Hydrochloride
/Dolutegravir
/Ethacridine Lactate Monohydrate
/Metoclopramide
/Metaraminol Bitartrate
/Moxifloxacin Hydrochloride
/2-Chloro-4-Nitrobenzoic Acid
/Bictegravir
/Methyl 4-Acetamido-2-Methoxybenzoate
/Methyl 4-Acetamido-5-Chloro-2-Methoxybenzoate
/Bromhexine Hydrochloride
/4-Aminosalicylic Acid
CAS:150683-30-0
Molecular Formula:C26H25ClN2O3
Alias
More Information
N-[4-(7-Chloro-5-Hydroxy-2,3,4,5-Tetrahydro-1-Benzazepine-1-Carbonyl)-3-Methylphenyl]-2-Methylbenzamide; Samsca; Benzazepine Derivative,32; N-[4-(9-Chloro-6-Hydroxy-2-Azabicyclo[5.4.0]Undeca-8,10,12-Triene-2-Carbonyl)-3-Methyl-Phenyl]-2-Methyl-Benzamide; N-[4-[(5R)-7-Chloro-5-Hydroxy-2,3,4,5-Tetrahydro-1-Benzazepine-1-Carbonyl]-3-Methylphenyl]-2-Methylbenzamide; Opc 41061; Tolvaptan Tablets
Brief Introduction
Tovaptan was developed by Otsuka company of Japan and approved by FDA in 2009 for the treatment of patients with heart failure. The trade name of tovaptan tablets is sumeka. The difficulty of its synthesis route is mainly reflected in the construction of benzo seven membered ring. The treatment of heart failure is a research hotspot, and the development of new diuretics is one of its strategic objectives. Therefore, antagonizing arginine vasopressin is an effective method to prevent the development of heart failure.
CNY 3 Million
33300m²
100-500 People
Manufacturing
Manufacturing
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Tolvaptan
/N-[3-Fluoro-4-[(Methylamino)Carbonyl]Phenyl]-2-Methylalanine
/4-Isothiocyanato-2-(Trifluoromethyl)Benzonitrile
/L-Prolinamide
/1,2,3,4-Tetrahydro-Benzo[b]Azepin-5-one
CAS:160970-54-7
Molecular Formula:C25H32F3N3O4
Alias
More Information
Trifluoroethoxy)Phenoxy]Ethyl]Amino]Propyl]-1H-Indole-7-Carboxamide; Trifluoroethoxy)Phenoxy]Ethylamino]Propyl]-2,3-Dihydroindole-7-Carboxamide; 1H-Indole-7-Carboxamide, 2,3-Dihydro-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-Trifluoroethoxy)Phenoxy]Ethyl]Amino]Propyl]-; 1-(3-Hydroxypropyl)-5-[(2R)-({2-[2-[2-(2,2,2-; 1-(3-Hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-Trifluoroethoxy)Phenoxy]Ethylamino]Propyl]-2,3-Dihydroindole-7-Carboxamide
Brief Introduction
Cilodoxin is a α- 1 adrenergic receptor antagonist for the treatment of symptoms associated with benign prostatic hyperplasia (BPH).
CNY 347.9 Million
53280m²
1000+ People
Manufacturer
Manufacturing
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
5kg /
BOTTLE
|
Main products:
Silodosin
/Candesartan Cilexetil
/Ezetimibe
/Irbesartan
/Losartan Potassium
/Montelukast Sodium
/Olmesartan Medoxomi
/Sitagliptin Phosphate Monohydrate
/Telmisartan
/Valsartan
CAS:168828-81-7
Molecular Formula:C18H19FN2O3
Alias
More Information
N-Benzyloxycarbonyl-3-Fluoro-4-Morpholinoaniline; (3-Fluoro-4-Morpholinophenyl)Carbamic Acid Benzyl Ester; Benzyl N-(3-Fluoro-4-Morpholin-4-Ylphenyl)Carbamate; N-Carbobenzoxy-3-Fluoro-4-Morpholinyl-Aniline; N-[3-Fluoro-4-(4-Morpholinyl)Phenyl]Carbamic Acid (Phenylmethyl) Ester; Carbamic Acid, N-[3-Fluoro-4-(4-Morpholinyl)Phenyl]-, Phenylmethyl Ester; Linezolid Intermediate
Brief Introduction
Benzyl [3-fluoro-4 - (4-morpholinyl) phenyl] carbamate is a synthetic intermediate of linezolid dimer, which is an impurity of antibacterial agent linezolid.
CNY 15 Million
13986m²
50-100 People
Manufacturing
Manufacturing
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Tech Grade | - | - |
20kg /
Fibre Drum
25kg /
Fibre Drum
|
Main products:
Benzyl (3-Fluoro-4-Morpholinophenyl)Carbamate
/Salicylaldehyde
/O-Methoxybenzaldehyde
/2-Formylbenzenesulfonic Acid Sodium Salt
/N-Methylol Acrylamide
/Laurocapram
/Diacetone Acrylamide
/[(2S)-1-Acetamido-3-Chloropropan-2-yl] Acetate
CAS:174671-46-6
Molecular Formula:C7H6BFO2
Alias
More Information
5-Fluoro-1-Hydroxy-3H-2,1-Benzoxaborole; An 2690; Onychomycosis; Unii-K124A4Euq3; 5-Fluoro-1,3-Dihydro-2,1-Benzoxaborol-1-Ol; 5-Fluoro-3H-Benzo[C][1,2]Oxaborol-1-Ol; 5-Fluoro-1,3-Dihydro-1-Hydroxy-2,1-Benzoxaborole; 1,3-Dihydro-5-Fluoro-1-Hydroxy-2,1-Benzoxaborole; 5-Fluorobenzo[C][1,2]Oxaborol-1(3H)-Ol; Tavaborole (Usan); 2,1-Benzoxaborole,5-Fluoro-1,3-Dihydro-1-Hydroxy
Brief Introduction
Tavaborole (AN2690, trade name Kerydin) is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole began its Phase 3 trials in December 2010 and was approved in July 2014. Tavaborole inhibits an essential fungal enzyme, leucyl-tRNA synthetase, that is required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and then cell death, eliminating the fungal infection.
CNY 20 Million
27972m²
Less Than 50 People
Manufacturing
Manufacturing
| Product Photo | Specification | Grade | Max Capacity | Certificates | Package | |
|---|---|---|---|---|---|---|
|
||||||
| Pharm Grade | - | - |
25kg /
Fibre Drum
|
Main products:
Tavaborole
/Oseltamivir Phosphate
/Vonoprazan Fumarate
/Edoxaban
/Ticagrelor
/Orlistat
/2-[2-Butyl-4-Methyl-6-Oxo-1-[[4-[2-(2H-Tetrazol-5-Yl)Phenyl]Phenyl]Methyl]Pyrimidin-5-Yl]-N,N-Dimethylethanethioamide
/Fluvoxamine Maleate
/2-[(4-Methoxy-3-Methylpyridin-2-Yl)Methylsulfinyl]-6-Pyrrol-1-Yl-1H-Benzimidazole
/Zonisamide
/Edoxaban Tosylate
/Edoxaban(Tosylate Monohydrate)
/Triprolidine Hydrochloride
/Doxylamine Succinate
/Carbinoxamine Maleate
/Prasugrel Hydrochloride
/Fluvoxketone
/5-Pyrrol-1-Yl-1,3-Dihydrobenzimidazole-2-Thione
/2-(2-Butyl-4-Hydroxy-6-Methylpyrimidin-5-yl)-N,N-Dimethylacetamide
/Oseltamivir Intermediate
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!